Cancer is the second leading cause of death

The sooner we detect cancer, the better chance we have to cure it.

Unlike other diseases, there is no single identifiable symptom or sign, nor test that can alert healthcare professionals to a potential cancer diagnosis. Recognizing the barriers and complexities to early cancer detection, C the Signs uses an evidence-driven approach to determine a patient's risk of cancer at the earliest and most curable stage of the disease.

grid of various facesgrid of various faces

Cancer is time sensitive

At the early stages when the cancer is localized, cure rates are as high as 90%. However, at the later stages, when the cancer has spread, survival can drop significantly to less than 30%.

Each month a cancer diagnosis is delayed, the risk of death increases by 10%

With over 200 types of cancers that can present anywhere in the body, at any age, with any combination of signs, symptoms or risk factors, cancer is extremely difficult to recognize in the early stages.

Over 85% of cancers are diagnosed in patients experiencing symptoms, yet a failure to recognize these signs early leads to delays in diagnosis, the spread of disease and poorer outcomes.

Mortality due to cancer treatment delay

Adopted by over 1,000 organizations, covering 8 million lives

doctor high-fiving young kid with parent

C the SignsTM can detect over 50 different types of cancer, in the following categories:


Upper GI







Lower GI

Head and Neck



Brain and CNS cancer

Cancer of unknown primary


Jan 18, 2021

Use of routine national cancer waiting times dataset to evaluate cancer urgent referral in City and Hackney CCG following the implementation of C the Signs tool

Read more
Feb 10, 2021

Accelerating early identification of cancer in primary care using an artificial intelligence driven solution

Read more